Lithocarpus polystachyus Rehd. leaves aqueous extract inhibits learning and memory impairment in Alzheimer's disease rats: Involvement of the SIRT6/NLRP3 signaling pathway

Abstract

Alzheimer's disease (AD) is a chronic and progressive neurodegenerative condition that is influenced by multiple factors along with neuroinflammation and oxidative stress. Our previous study proved that Lithocarpus polystachyus Rehd. aqueous extract (sweet tea aqueous extract, STAE) effectively inhibits hydrogen peroxide-induced neuronal cell injury. However, it is not clear whether STAE can protect against AD, and its underlying mechanisms are still uncertain. Therefore, the present study was designed to evaluate the possible behavioral and neurochemical effects of STAE on Aβ_25-35-induced AD rats administered STAE (20, 40, 80 mg/mL) for 14 days. We showed that STAE administration significantly and dose-dependently ameliorated the cognitive deficits in the AD rat models, assessed in the Morris water maze (MWM) test, Y-maze test, and novel object recognition (NOR) test. The results of hematoxylin and eosin (H&E) staining and Nissl staining showed that after treatment with STAE, the pathological damage to the hippocampal CA1, CA3, and dentate gyrus (DG) neurons of rats was significantly improved. Furthermore, STAE dose-dependently inhibited microglia and astrocyte activation in the hippocampus of rats accompanied by increased protein expression of silent mating-type information regulation 2 homolog 6 (SIRT6) and decreased protein expression of nod-like receptor thermal protein domain-associated protein 3 (NLRP3) and its downstream pyroptosis-related genes after following Aβ_25-35. In summary, our findings indicate that STAE effectively inhibits Aβ_25-35-induced learning and memory impairment in rats, and the mechanism is, at least partially, related to the regulation of SIRT6/NLRP3 signaling pathway.

Keywords

Alzheimer's disease / Lithocarpus polystachyus Rehd. / neuroinflammation / NLRP3 inflammasome / oxidative stress / SIRT6

References

[1] Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021; 7(1): 33.

[2] Self WK, Holtzman DM. Emerging diagnostics and therapeutics for Alzheimer disease. Nature Med. 2023; 29(9): 2187-2199.

[3] Hampel H, Vergallo A, Iwatsubo T, et al. Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementation. Alzheimer's Dementia. 2022; 18(10): 1993-2002.

[4] Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL. Synaptic degeneration in Alzheimer disease. Nat Rev Neurol. 2023; 19(1): 19-38.

[5] Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discovery. 2022; 21(4): 306-318.

[6] Uddin MS, Lim LW. Glial cells in Alzheimer's disease: from neuropathological changes to therapeutic implications. Ageing Res Rev. 2022; 78:101622.

[7] Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021; 17(3): 157-172.

[8] Kim J, Lim J, Yoo ID, Park S, Moon JS. TXNIP contributes to induction of pro-inflammatory phenotype and caspase-3 activation in astrocytes during Alzheimer's diseases. Redox Biol. 2023; 63:102735.

[9] Geng Y, Wang Z, Zhou J, Zhu M, Liu J, James TD. Recent progress in the development of fluorescent probes for imaging pathological oxidative stress. Chem Soc Rev. 2023; 52(11): 3873-3926.

[10] Zilberter Y, Tabuena DR, Zilberter M. NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders. Prog Neurobiol. 2023; 231:102539.

[11] Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer's disease. The Lancet. 2021; 397(10284): 1577-1590.

[12] Wang Y, Cai Z, Zhan G, et al. Caffeic acid phenethyl ester suppresses oxidative stress and regulates M1/M2 microglia polarization via Sirt6/Nrf2 pathway to mitigate cognitive impairment in aged mice following anesthesia and surgery. Antioxidants. 2023; 12(3):714.

[13] Chou V, Pearse RV, Aylward AJ, et al. INPP5D regulates inflammasome activation in human microglia. Nat Commun. 2023; 14(1): 7552.

[14] Zhou Y, Fan X, Jiao T, et al. SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation. Acta Pharm Sin B. 2021; 11(1): 89-99.

[15] Li L, Hua R, Hu K, et al. SIRT6 deficiency causes ovarian hypoplasia by affecting Plod1-related collagen formation. Aging cell. 2023; 23(2):e14031.

[16] Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023; 41: 301-316.

[17] Ma Q. Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction. Pharmacol Rev. 2023; 75(3): 487-520.

[18] Liu C, Yao K, Tian Q, et al. CXCR4-BTK axis mediate pyroptosis and lipid peroxidation in early brain injury after subarachnoid hemorrhage via NLRP3 inflammasome and NF-κB pathway. Redox Biol. 2023; 68:102960.

[19] Moonen S, Koper MJ, Van Schoor E, et al. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 2023; 145(2): 175-195.

[20] Vande Walle L, Lamkanfi M. Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discovery. 2023; 23: 43-66.

[21] Yao H, Zhang D, Yu H, et al. Gut microbiota regulates chronic ethanol exposure-induced depressive-like behavior through hippocampal NLRP3-mediated neuroinflammation. Mol Psychiatry. 2023; 28(2): 919-930.

[22] Sun YY, Zhu HJ, Zhao RY, et al. Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice. Redox Biol. 2023; 66:102852.

[23] Shang A, Liu HY, Luo M, et al. Sweet tea (Lithocarpus polystachyus Rehd.) as a new natural source of bioactive dihydrochalcones with multiple health benefits. Crit Rev Food Sci Nutr. 2022; 62(4): 917-934.

[24] Gao J, Xu Y, Zhang J, Shi J, Gong Q. Lithocarpus polystachyus Rehd. leaves aqueous extract protects against hydrogen peroxide‑induced SH-SY5Y cells injury through activation of Sirt3 signaling pathway. Int J Mol Med. 2018; 42(6): 3485-3494.

[25] Hou S, Chen S, Huang S, et al. The hypoglycemic activity of Lithocarpus polystachyus Rehd. leaves in the experimental hyperglycemic rats. J Ethnopharmacol. 2011; 138(1): 142-149.

[26] Lei M, Chen N, Xu Y, Gong Q, Gao J. Lithocarpus polystachyus (Sweet Tea) water extract promotes human hepatocytes HL7702 proliferation through activation of HGF/AKT/ERK signaling pathway. Chin Her Med. 2022; 14(4): 576-582.

[27] Liu X, Ganguly P, Jin Y, et al. Tachykinin neuropeptides and amyloid β (25-35) assembly: friend or Foe? J Am Chem Soc. 2022; 144(32): 14614-14626.

[28] Gong QH, Wang Q, Pan LL, Liu XH, Xin H, Zhu YZ. S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-κB pathway in rats. Brain Behav Immun. 2011; 25(1): 110-119.

[29] Gao J, Chen N, Li N, et al. Neuroprotective effects of trilobatin, a novel naturally occurring Sirt3 agonist from Lithocarpus polystachyus Rehd., mitigate cerebral Ischemia/Reperfusion injury: involvement of TLR4/NF-κB and Nrf2/Keap-1 signaling. Antioxid Redox Signaling. 2020; 33(2): 117-143.

[30] Gao J, Zhang X, Shu G, et al. Trilobatin rescues cognitive impairment of Alzheimer's disease by targeting HMGB1 through mediating SIRT3/SOD2 signaling pathway. Acta Pharmacol Sin. 2022; 43(10): 2482-2494.

[31] Gao J, Ma C, Xia D, et al. Icariside II preconditioning evokes robust neuroprotection against ischaemic stroke, by targeting Nrf2 and the OXPHOS/NF-κB/ferroptosis pathway. Br J Pharmacol. 2023; 180(3): 308-329.

[32] Feng L, Li Y, Lin M, et al. Trilobatin attenuates cerebral ischaemia/reperfusion-induced blood-brain barrier dysfunction by targeting matrix metalloproteinase 9: the legend of a food additive. Br J Pharmacol. 2023; 181: 1005-1027.

[33] He T, Shang J, Gao C, et al. A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2/FOXC1 axis. Acta Pharm Sin B. 2021; 11(3): 708-726.

[34] Akter R, Afrose A, Rahman MR, et al. A comprehensive analysis into the therapeutic application of natural products as SIRT6 modulators in Alzheimer's disease, aging, cancer, inflammation, and diabetes. Int J Mol Sci. 2021; 22(8):4180.

[35] Gao F, Hu M, Zhang J, Hashem J, Chen C. TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury. Acta Neuropathol. 2022; 144(2): 187-210.

[36] Madhu LN, Kodali M, Attaluri S, et al. Melatonin improves brain function in a model of chronic Gulf war illness with modulation of oxidative stress, NLRP3 inflammasomes, and BDNF-ERK-CREB pathway in the hippocampus. Redox Biol. 2021; 43:101973.

[37] Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Giuffrida Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci. 2007; 8(10): 766-775.

[38] Pinky Neha, Neha M, Ali M, et al. Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer's disease: critical role of the restoration of neuronal circuits. Ageing Res Rev. 2023; 91:102069.

[39] Balakrishnan R, Park JY, Cho DY, et al. AD-1 small molecule improves learning and memory function in Scopolamine-induced amnesic mice model through regulation of CREB/BDNF and NF-κB/MAPK signaling pathway. Antioxidants. 2023; 12(3):648.

[40] Tang JJ, Huang LF, Deng JL, et al. Cognitive enhancement and neuroprotective effects of OABL, a sesquiterpene lactone in 5xFAD Alzheimer's disease mice model. Redox Biol. 2022; 50:102229.

[41] Lapenna D. Glutathione and glutathione-dependent enzymes: from biochemistry to gerontology and successful aging. Ageing Res Rev. 2023; 92:102066.

[42] Neculicioiu VS, Colosi IA, Costache C, et al. Sleep deprivation-induced oxidative stress in rat models: a scoping systematic review. Antioxidants. 2023; 12(8):1600.

[43] Fang Z, Xu Y, Liu G, et al. Narirutin activates TFEB (transcription factor EB) to protect against acetaminophen-induced liver injury by targeting PPP3/calcineurin. Autophagy. 2023; 19(8): 2240-2256.

[44] Hosoki S, Hansra GK, Jayasena T, et al. Molecular biomarkers for vascular cognitive impairment and dementia. Nat Rev Neurol. 2023; 19(12): 737-753.

[45] Surai PF, Earle-Payne K, Kidd MT. Taurine as a natural antioxidant: from direct antioxidant effects to protective action in various toxicological models. Antioxidants. 2021; 10(12):1876.

[46] Mancuso C, Capone C, Ranieri SC, et al. Bilirubin as an endogenous modulator of neurotrophin redox signaling. J Neurosci Res. 2008; 86(10): 2235-2249.

[47] Platania CBM, Pittalà V, Pascale A, et al. Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells. Biochem Pharmacol. 2020; 175:113908.

[48] Calabrese V, Renis M, Calderone A, Russo A, Barcellona ML, Rizza V. Stress proteins and SH-groups in oxidant-induced cell damage after acute ethanol administration in rat. Free Radic Biol Med. 1996; 20(3): 391-397.

[49] Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signaling. 2010; 13(11): 1763-1811.

[50] Calabrese EJ, Kozumbo WJ. The phytoprotective agent sulforaphane prevents inflammatory degenerative diseases and age-related pathologies via Nrf2-mediated hormesis. Pharmacol Res. 2021; 163:105283.

RIGHTS & PERMISSIONS

2024 The Author(s). Ibrain published by Affiliated Hospital of Zunyi Medical University (AHZMU) and Wiley-VCH GmbH.